Bavarian Biotech Report 2011/2012 (7MB) - Bio M

SERVIER Deutschland GmbHPHARMA & CHEMICAL INDUSTRYContact:Horst StemmerElsenheimer Str. 53D-80687 MünchenPhone: +49 (0) 89 57095-01Fax: +49 (0) 89 57095-126E-Mail: info@de.netgrs.comInternet: www.servier.deKeywords: Pharma Industry Drug Development, Clinical Research, Bone /Joint Diseases, Cardiovascular Diseases, CNS, DiabeticsFollowing its international success, SERVIER Deutschland GmbH has establishedan independent branch in Munich since 1996. SERVIER is one of thevery dynamic pharmaceutical companies in Germany, experiencing agrowth-rate in double figures on average. The reason for this is not only theapproved and merchandised drugs but also new, innovative products. Thesuccess of the new drugs is supported by the SERVIER Forschung undPharma-Entwicklung GmbH (also in Munich), which manages many differentprojects throughout the German-speaking region.Contact:Dr. Udo SticherEschenstr. 5D-82024 TaufkirchenPhone: +49 (0) 89 6513-1504Fax: +49 (0) 89 6513-1399E-Mail: udo.sticher@sial.comInternet: www.sigma-aldrich.comSigma-Aldrich Chemie GmbHBIOTECH DEVICES & REAGENTSKeywords: Proteomics, Antibody, Genomics, CNS, Small Molecules, KnockOut, PCRSigma-Aldrich is a leading Life Science and High Technology company. Ourbiochemical and organic chemical products and kits are used in scientificand genomic research, biotechnology, pharmaceutical development, the diagnosisof disease and as key components in pharmaceutical and other hightechnology manufacturing. We have customers in life science companies,university and government institutions, hospitals and in industry. Sigma-Aldrich operates in 36 countries and has over 7,600 employees providingexcellent service worldwide.SiNatur GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSContact:Dr. Franz KerekAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 856625-55Fax: +49 (0) 89 856625-56E-Mail: kerek@sinatur.netInternet: www.sinatur.netKeywords: Diabetics, Metabolic DiseasesSiNatur owns the patent rights for the structure, preparation and medicinalapplications Sub-Nano-Silicic Acid (SNSA). This recently discovered SNSA isthe first biologically active form of silicic acid and of silicon generally. Thesubstance is a potent inhibitor of P-type ATPases and of certain Protein-Phosphatases with IC50 in the nanomolar range.Due to the ubiquitous presence of Si in living organisms the discovery ofthe first biological active form of this element will have a broad scientificand practical impact.SiNatur is developing medicinal applications of SNSA first of all in the therapyof diabetes and of gastric hyperacidity.110